VSEE HEALTH, INC. Cash Flow Statement
VSEE|2 years of annual SEC 10-K data (FY2024-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 2 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$6M
FY2025
Free Cash Flow
-$6M
FY2025
Capital Expenditures
$55,267
Cash used for long-term assets
Dividends Paid
N/A
FY2025
VSEE HEALTH, INC. used $6M in operating cash flow and negative free cash flow of $6M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 |
|---|---|---|
| Net Income | -$57.7M | -$530.0K |
| Depreciation & Amortization | $1.3M | $678 |
| Operating Cash Flow | -$5.8M | -$632.6K |
| Capital Expenditures | $55.3K | $4.3K |
| Free Cash Flow | -$5.8M | -$636.9K |
| Share Buybacks | $5.2K | - |
| FCF Margin | -56.1% | -40.4% |